Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Liabilities: 2020-2025

Historic Total Liabilities for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $3.4 billion.

  • Core Scientific's Total Liabilities rose 107.35% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 107.35%. This contributed to the annual value of $2.4 billion for FY2024, which is 84.78% up from last year.
  • As of Q3 2025, Core Scientific's Total Liabilities stood at $3.4 billion, which was up 12.53% from $3.0 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Total Liabilities ranged from a high of $3.4 billion in Q3 2025 and a low of $29.8 million during Q1 2021.
  • For the 3-year period, Core Scientific's Total Liabilities averaged around $1.8 billion, with its median value being $1.7 billion (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 263,294,400.00% in 2021, then dropped by 26.62% in 2023.
  • Core Scientific's Total Liabilities (Quarterly) stood at $1.1 billion in 2021, then rose by 15.56% to $1.2 billion in 2022, then rose by 7.56% to $1.3 billion in 2023, then spiked by 84.78% to $2.4 billion in 2024, then soared by 107.35% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q3 2025, $3.0 billion for Q2 2025, and $1.8 billion during Q1 2025.